Schistosomiasis

Infectious Disease Clinics of North America

Volumn 26, Issue 2, 2012, Pages 383-397

  Gryseels, Bruno ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Bilharzia; Helminths; Neglected tropical diseases; Praziquantel; Schistosoma haematobium; Schistosoma japonicum; Schistosoma mansoni; Schistosomiasis

Indexed keywords

ARTEMISININ; PRAZIQUANTEL;

ACUTE DISEASE; CHRONIC DISEASE; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ENVIRONMENTAL SANITATION; ERADICATION THERAPY; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTESTINE INFECTION; MALAISE; NAUSEA; NEUROSCHISTOSOMIASIS; NONHUMAN; PARASITE IMMUNITY; PARASITE PREVALENCE; PARASITE TRANSMISSION; PARASITE VIRULENCE; PARASITIC LIVER DISEASE; RECOMMENDED DRUG DOSE; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SINGLE DRUG DOSE; SPLEEN DISEASE; TREATMENT DURATION; TREATMENT PLANNING; URINARY TRACT INFECTION;

ACUTE DISEASE; ANIMALS; ANTHELMINTICS; CHRONIC DISEASE; HUMANS; PRAZIQUANTEL; SANITATION; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 84861477130     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2012.03.004     Document Type: Review

References (43)

1. Jordan P., Webbe G., Sturrock F.S. Human schistosomiasis 1993, CAB International, Wallingford (CT).
2. Ross A.G., Bartley P.B., Sleigh A.C., et al. Schistosomiasis. N Engl J Med 2002, 346:1212-1220.
3. Gryseels B., Polman K., Clerinx J., et al. Human schistosomiasis. Lancet 2006, 368:1106-1118.
4. Doumenge J.P., Mott K.E. Global distribution of schistosomiasis: CEGET/WHO Atlas. World Health Stat Q 1984, 37:186-199.
5. Brown D.S. Freshwater snails of Africa and their medical importance 1994, Taylor and Francis, London. 2nd edition.
6. Ross A.G., Sleigh A.C., Li Y., et al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 2001, 14:270-295.
7. Chitsulo L., Engels D., Montresor A., et al. The global status of schistosomiasis and its control. Acta Trop 2000, 77:41-51.
8. WHO Expert Committee Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 2002, 912:1-57.
9. Global burden of disease: update 2004 2008, World Health Organization, Geneva (Switzerland).
10. Jordan P. From Katayama to the Dakhla Oasis: the beginning of epidemiology and control of bilharzia. Acta Trop 2000, 77:9-40.
11. Steinmann P., Keiser J., Bos R., et al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006, 6:411-425.
12. Jelinek T., Nothdurft H.D., Loscher T. Schistosomiasis in travelers and expatriates. J Travel Med 1996, 13:160-164.
13. Ross A.G., Vickers D., Olds G.R., et al. Katayama syndrome. Lancet Infect Dis 2007, 7:218-224.
14. Clerinx J., Van Gompel A. Schistosomiasis in travellers and migrants. Travel Med Infect Dis 2011, 9:6-24.
15. Wilson M.S., Mentink-Kane M.M., Pesce J.T., et al. Immunopathology of schistosomiasis. Immunol Cell Biol 2007, 85:148-154.
16. King C.H., Dickman K., Tisch D.J. Regauging the cost of chronic helminthic infection: meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365:1561-1569.
17. Vennervald B.J., Polman K. Helminths and malignancy. Parasite Immunol 2009, 31:686-696.
18. Strickland G.T. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006, 43:915-922.
19. Schwartz E. Pulmonary schistosomiasis. Clin Chest Med 2002, 23:433-443.
20. Barsoum R., Harrington J.T., Mathew C.M., et al. The changing face of schistosomal glomerulopathy. Kidney Int 2004, 66:2472-2484.
21. WHO Report of an informal working group meeting on urogenital schistosomiasis and HIV transmission 2010, World Health Organization, Geneva (Switzerland).
22. Carod-Artal F.J. Neuroschistosomiasis. Expert Rev Anti Infect Ther 2010, 8:1307-1318.
23. Ross A.G., McManus D.P., Farrar J., et al. Neuroschistosomiasis. J Neurol 2012, 259:22-32.
24. Rabello A. Diagnosing schistosomiasis. Mem Inst Oswaldo Cruz 1997, 92:669-676.
25. de Vlas S.J., Gryseels B. Underestimation of Schistosoma mansoni prevalences. Parasitol Today 1992, 8:274-277.
26. Tsang V.C., Wilkins P.P. Immunodiagnosis of schistosomiasis. Immunol Invest 1997, 26:175-188.
27. Van Lieshout L., Polderman A.M., Deelder A.M. Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections. Acta Trop 2000, 77:69-80.
28. Clerinx J., Bottieau E., Wichmann D., et al. Acute Schistosomiasis in a Cluster of Travelers From Rwanda: Diagnostic Contribution of Schistosome DNA Detection in Serum Compared to Parasitology and Serology. J Travel Med 2011, 18:367-372.
29. Lengeler C., Utzinger J., Tanner M. Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa. Bull World Health Organ 2002, 80:235-242.
30. Tan H., Yang M., Wu Z., et al. Rapid screening method for Schistosoma japonicum infection using questionnaires in flood area of the People's Republic of China. Acta Trop 2004, 90:1-9.
31. Palmer PE, Reeder CC. International Registry of Tropical Imaging. Radiology Department, Uniformed Services University USA 2011. Available at: Accessed February 8, 2012. http://tmcr.usuhs.mil.
32. Richter J., Hatz C., Haussinger D. Ultrasound in tropical and parasitic diseases. Lancet 2003, 362:900-902.
33. Olds G.R., Dasarathy S. Schistosomiasis. Curr Treat Options Infect Dis 2000, 2:88-99.
34. Dayan A.D. Albendazole, mebendazole and praziquantel: review of non-clinical toxicity and pharmacokinetics. Acta Trop 2003, 86:141-159.
35. Gryseels B., Mbaye A., de Vlas S.J., et al. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 2001, 6:864-873.
36. Richter J. The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop 2003, 86:161-183.
37. Utzinger J., Xiao S.H., Tanner M., et al. Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs 2007, 8:105-116.
38. Minai M., Hosaka Y., Ohta N. Historical view of schistosomiasis japonica in Japan: implementation and evaluation of disease-control strategies in Yamanashi Prefecture. Parasitol Int 2003, 52:321-326.
39. Molyneux D.H., Hotez P.J., Fenwick A " Rapid-impact interventions" : how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2005, 2:e336.
40. WHO Preventive chemotherapy in human helminthiasis 2006, World Health Organisation, Geneva (Switzerland).
41. Available at: Accessed February 8, 2012. http://www.gatesfoundation.org/press-releases/Pages/combating-10-neglected-tropical-diseases-120130.aspx.
42. Geerts S., Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin Microbiol Rev 2000, 13:207-222.
43. Mahmoud A., Zerhounic E. Neglected tropical diseases: moving beyond mass drug treatment to understanding the science. Health Aff (Millwood) 2009, 28:1726-1733.